Warner Bros. and DC Studios are testing a lower-budget, genre-focused theatrical strategy with the release of Clayface, an R-rated body-horror thriller opening in North American and UK theaters on Friday, October 23, 2026. Directed by James Watkins from a screenplay written by Mike Flanagan in December 2011, the standalone origin story centers on Batman adversary Matt Hagen, a rising Hollywood actor whose face is severely disfigured by a mob boss after kissing the wrong girl at a party, prompting him to volunteer for an experimental medical procedure that transforms his body into living clay. The film generated an estimated $3.5 million or more in Thursday previews that began at 2 p.m., positioning the project for a projected $45 million to $55 million worldwide debut across 76 international markets and more than 3,400 North American locations.

Competing Box Office Forecasts and Preview Benchmarks

Industry projections for the opening weekend of Clayface vary across studios and tracking services. According to The Hollywood Reporter, Warner Bros. anticipates a North American opening between $25 million and $30 million. Meanwhile, Variety reports that initial tracking ranged from $25 million to $35 million, whereas rival studio estimates suggest a slightly softer domestic debut between $22 million and $28 million. Following Thursday's $3.5 million preview haul, Deadline placed domestic weekend forecasts between $20 million and $25 million, noting that a first-place finish would give the newly combined Paramount-Warner Bros. its second consecutive No. 1 opener following last weekend's Street Fighter ($31 million).

Overseas, the film is projected to earn between $20 million and $25 million, bringing its global opening outlook to $45 million to $55 million. Thursday's preview performance outpaced Sony and Marvel's R-rated Kraven the Hunter ($2 million previews toward an $11 million opening) and trailed just behind DC's pre-pandemic PG-13 release Birds of Prey ($4 million previews toward a $33 million debut). Within the horror genre, the preview numbers closely mirror Blumhouse Atomic Monster's Other Mommy ($3.6 million previews, $27.8 million opening) and top 2022's Smile ($2 million previews, $22.6 million opening) as well as Digger ($1.2 million previews, $8 million opening).

Critics have responded more favorably to the horror shift than to several recent comic book adaptations. Clayface holds a 76% Certified Fresh rating on Rotten Tomatoes, outscoring recent DC titles including The Flash (63%), Supergirl (52%), Shazam! Fury of the Gods (49%), Aquaman and the Lost Kingdom (33%), and Joker: Folie à Deux (31%), while landing near Birds of Prey (79%).

Production Economics and DC's Mid-Budget History

For DC Studios co-chiefs Peter Safran and James Gunn, Clayface represents a deliberate pivot toward contained genre filmmaking. Shot in the United Kingdom, the feature carries a net production cost of $44 million before marketing and distribution expenses, according to Variety and Deadline, though secondary reports from Comic Basics and Screen Rant cite a lower range between $30 million and $40 million.

That outlay is a fraction of the studio's tentpole releases. After 2025's Superman reset the DC Universe, this past July's Supergirl struggled theatrically, grossing $126 million globally against a $170 million production budget. By keeping costs near $44 million, DC Studios lowers the theatrical threshold required for profitability.

Warner Bros. has periodically experimented with low-to-mid-budget comic adaptations with mixed financial outcomes. In 2005, the R-rated DC Vertigo adaptation V for Vendetta, produced by the Wachowski sisters on a $50 million budget, opened at No. 1 in North America with $25.6 million before finishing with $70.5 million domestically and $134.7 million worldwide. Conversely, two 2010 releases struggled: The Losers cost $25 million, opened to $9.4 million, and ended its domestic run at $23.5 million, while the $47 million fantasy western Jonah Hex opened to $5.3 million and closed with $10.5 million in North America.

The Battle for No. 1 and All-Time R-Rated Milestones

Despite wide theater availability, Clayface faces an unexpected challenge for the top domestic box office spot from A24's Elizabeth Holmes documentary You Can See Everything. Co-directed by Nathan Fielder and Lance Oppenheim, the documentary opened to $15.6 million across 855 theaters last weekend—the largest debut for a nonmusical documentary in two decades. According to Deadline, the film reached an $18.1 million North American cumulative total early in the week, while Variety noted its domestic tally hit $20.8 million ahead of Friday's expansion into 2,600 venues. Projections indicate You Can See Everything could collect $20 million to $25 million in its second frame, creating a tight race for first place.

Several smaller wide and limited releases are also entering the market this weekend with single-digit projections. Laika Studios' stop-motion animated feature Wildwood, directed by Travis Knight, earned roughly $1 million in Fathom previews and is tracking for a $6 million to $8 million opening across more than 2,000 theaters—the studio's first release since 2019's Missing Link ($6 million opening, $26 million global total). Black Bear's Sundance romantic comedy Wicker, starring Olivia Colman and Alexander Skarsgård and acquired for $2.5 million, is also projected to earn $6 million to $8 million from 1,471 locations. Sacha Baron Cohen's mockumentary Ali G: Who Iz I? and the Jenna Ortega literary adaptation Klara and the Sun round out the weekend slate.

Beyond opening weekend charts, some box office commentary has measured the film against historical R-rated records. According to Koimoi, citing Box Office Mojo data, Clayface would need to surpass The Matrix Reloaded ($281.6 million domestic) by earning more than $282 million in North America to enter the all-time top 10 highest-grossing R-rated movies. However, critical assessments such as Screen Daily emphasize that the graphic body-horror spin-off is designed for genre scale rather than traditional four-quadrant superhero blockbuster totals.

Frequently Asked Questions

What specific ranking is referenced in top 10 box office discussions for Clayface?

The $282 million benchmark cited by Koimoi refers to the all-time top 10 highest-grossing R-rated films in North American lifetime box office history, where The Matrix Reloaded currently sits at No. 10 with $281.6 million unadjusted for inflation. It does not measure horror-only openings or global totals, and current trade tracking does not project Clayface to reach that lifetime domestic tier.

How much will You Can See Everything affect Clayface's opening weekend?

As A24 expands You Can See Everything from 855 theaters to 2,600 locations, its projected $20 million to $25 million second weekend directly overlaps with Clayface's domestic forecast range. While Clayface holds a wider footprint of more than 3,400 theaters, strong midweek holdover business for the documentary could split adult moviegoing audiences and determine which studio claims the domestic No. 1 spot.

How is the $44 million production budget evaluated alongside marketing costs?

The reported $44 million figure represents the net production cost before print and advertising (P&A) expenses. While studios do not publicly disclose marketing budgets in pre-release trade reports, keeping production costs at $44 million—compared to $170 million for Supergirl—significantly reduces the financial risk for Warner Bros. if the film hits its $45 million to $55 million global opening target.

Sources